AppliedVR released study results demonstrating VR’s ability to help patients suffering from chronic low back pain. The technology was able to increase participants' brain coherence and help them achieve a slower breathing rate — two metrics associated with reduced pain.
AppliedVR teamed up with the National Cancer Institute to study the feasibility of VR to alleviate anxiety in brain tumor patients undergoing imaging scans. The research partners recently announced interim analysis results from their clinical study — they said that not only would VR intervention be a feasible option to reduce patients’ anxiety, but that patients would report high satisfaction levels as well.
It may take some time to introduce VR into your skilled nursing facility, but it will be worth it for the physical, mental, and social benefit of your residents.
Virtual reality exceeds the traditional training methods facilities often use, and this new immersive, experiential way to train staff members is critical for their proficiency and satisfaction.
We have witnessed several people die alone during the pandemic without their family members or loved ones being beside them due to hospital regulations. Can VR and holograms reduce the emotional burden for families, patients and clinicians in future crises when patients can't be with their loved ones?
The Food and Drug Administration granted the company de novo clearance for its VR programs to help reduce chronic lower back pain. AppliedVR’s eight-week program is based on cognitive behavioral therapy.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The company is developing a digital therapeutic using VR to manage chronic lower back pain. It recently submitted an application for de novo clearance to the FDA.
The startup, which has FDA-cleared products for rehabilitation after a stroke or brain injury, plans to use the funds to expand into other indications and grow its presence in North America and Europe.
The startup is working with Curebase to launch five clinical trials to test its VR-based therapeutic for chronic pain. They plan to enroll a total of more than 2,000 people.
Haptics technology is a vital surgical training alternative because it lets surgeons interact with virtual environments by adding the sense of touch to the overall simulation.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Osso VR, which uses VR modules to prepare surgeons for hands-on training and demo medical devices, raised $27 million in funding.
Digital health startup AppliedVR shared results from a pivotal study of its platform for lower back pain relief. The company plans to submit the results to the FDA in the next year.
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of a 92-person virtual trial testing VR for pain management at home.
With VR technology becoming more accessible, it’s no longer just used in high-end gaming. Entrepreneurs have found several uses for virtual and augmented reality in healthcare, from a training tool to helping treat patients.
Informed by learnings from its collaboration with AARP, VRHealth announced at CES that it has launched a VR platform, which includes healthcare-related apps for consumers to use at home.
